Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability
- PMID: 35119630
- DOI: 10.1007/s11892-022-01447-2
Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability
Abstract
Purpose of review: Diabetes mellitus (DM) due to toxic misfolding of proinsulin variants provides a monogenic model of endoplasmic reticulum (ER) stress. The mutant proinsulin syndrome (also designated MIDY; Mutant INS-gene-induced Diabetes of Youth or Maturity-onset diabetes of the young 10 (MODY10)) ordinarily presents as permanent neonatal-onset DM, but specific amino-acid substitutions may also present later in childhood or adolescence. This review highlights structural mechanisms of proinsulin folding as inferred from phenotype-genotype relationships.
Recent findings: MIDY mutations most commonly add or remove a cysteine, leading to a variant polypeptide containing an odd number of thiol groups. Such variants are associated with aberrant intermolecular disulfide pairing, ER stress, and neonatal β-cell dysfunction. Non-cysteine-related (NCR) mutations (occurring in both the B and A domains of proinsulin) define distinct determinants of foldability and vary in severity. The range of ages of onset, therefore, reflects a "molecular rheostat" connecting protein biophysics to quality-control ER checkpoints. Because in most mammalian cell lines even wild-type proinsulin exhibits limited folding efficiency, molecular barriers to folding uncovered by NCR MIDY mutations may pertain to β-cell dysfunction in non-syndromic type 2 DM due to INS-gene overexpression in the face of peripheral insulin resistance. Recent studies of MIDY mutations and related NCR variants, combining molecular and cell-based approaches, suggest that proinsulin has evolved at the edge of non-foldability. Chemical protein synthesis promises to enable comparative studies of "non-foldable" proinsulin variants to define key steps in wild-type biosynthesis. Such studies may create opportunities for novel therapeutic approaches to non-syndromic type 2 DM.
Keywords: Folding efficiency; Insulin; Insulin biosynthesis; Monogenic diabetes; Protein folding.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Structural Lessons From the Mutant Proinsulin Syndrome.Front Endocrinol (Lausanne). 2021 Sep 30;12:754693. doi: 10.3389/fendo.2021.754693. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34659132 Free PMC article. Review.
-
Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical Correlation.Front Endocrinol (Lausanne). 2022 Mar 1;13:821069. doi: 10.3389/fendo.2022.821069. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35299972 Free PMC article.
-
Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes.Mol Aspects Med. 2015 Apr;42:105-18. doi: 10.1016/j.mam.2015.01.001. Epub 2015 Jan 8. Mol Aspects Med. 2015. PMID: 25579745 Free PMC article. Review.
-
Endoplasmic reticulum oxidoreductin-1α (Ero1α) improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress.J Biol Chem. 2013 Oct 25;288(43):31010-8. doi: 10.1074/jbc.M113.510065. Epub 2013 Sep 10. J Biol Chem. 2013. PMID: 24022479 Free PMC article.
-
Distinct states of proinsulin misfolding in MIDY.Cell Mol Life Sci. 2021 Aug;78(16):6017-6031. doi: 10.1007/s00018-021-03871-1. Epub 2021 Jul 10. Cell Mol Life Sci. 2021. PMID: 34245311 Free PMC article.
Cited by
-
A rare homozygous INS variant causes adult-onset diabetes.BMJ Open Diabetes Res Care. 2024 Dec 20;12(6):e004418. doi: 10.1136/bmjdrc-2024-004418. BMJ Open Diabetes Res Care. 2024. PMID: 39706672 Free PMC article.
-
Synthetic studies of the mutant proinsulin syndrome demonstrate correlation between folding efficiency and age of diabetes onset.Int J Pept Res Ther. 2025 Jan;31(1):11. doi: 10.1007/s10989-024-10665-z. Epub 2024 Nov 20. Int J Pept Res Ther. 2025. PMID: 39866851
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci. 1999;24(9):329–32. - PubMed
-
- Langkilde AE, Morris KL, Serpell LC, Svergun DI, Vestergaard B. The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy. Acta Crystallogr Sect D Biol Crystallogr. 2015;71(4):882–95.
-
- Eakin CM, Berman AJ, Miranker AD. A native to amyloidogenic transition regulated by a backbone trigger. Nat Struct Mol Biol. 2006;13(3):202–8. - PubMed
-
- Carrell RW, Gooptu B. Conformational changes and disease—serpins, prions and Alzheimer’s. Curr Opin Struct Biol. 1998;8(6):799–809. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials